Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study.

ABSTRACT:

Setting

Bariatric surgery is indicated for patients diagnosed with obesity and type 2 diabetes. Many patients achieve type 2 diabetes remission soon after bariatric surgery. Even though most maintain good glycemic control, remission is not maintained in all patients, and as a result, some patients may relapse. Type 2 diabetes relapse is common in patients who regain weight; weight regain is prevalent 1 to 2 years after surgery. Additional pharmacotherapy may be required to aid bariatric surgery in fostering weight loss and reducing blood glucose levels.

Objectives

The purpose of this clinical trial was to determine the effects of canagliflozin in participants who initially achieved type 2 diabetes remission but subsequently relapsed.

Methods

The double-blinded, random

SUBMITTER: Kashyap SR 

PROVIDER: S-EPMC7278903 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature